JB Chemicals Faces ₹6.8 Million Tax Demand: Impact on Pharmaceutical Giant's Financials

JB Chemicals and Pharmaceuticals Ltd, a leading Indian pharmaceutical company, has received a tax order demanding ₹6.8 million. This development comes amidst the company's recent financial performance, where it reported a 21.6% year-on-year increase in net profit to ₹162.5 crore for Q3 FY2025. The tax demand could potentially impact the company's financial outlook, although it represents a relatively small fraction of JB Chemicals' overall revenue, which grew by 14.1% to ₹963.5 crore in the same quarter. The company has been focusing on expanding its domestic formulations business and doubling its contract manufacturing revenue to $100 million over the next four years.

Source: Reuters